Julia H. Carter

Wood Hudson Cancer Research Laboratory — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

21h-index2.2kcitations98works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PI3K/AKT/mTOR signaling in cancer(10), TGF-β signaling in diseases(9), Cancer Research and Treatments(8), Genetic factors in colorectal cancer(7), Carcinogens and Genotoxicity Assessment(6)

Publications98 total

Supplemental Figures from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Supplemental Figures from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Data from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Data from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Supplemental Figures 1 through 9 and Supplemental Tables 1 and 2 from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Supplemental Figures 1 through 9 and Supplemental Tables 1 and 2 from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Supplemental Methods from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Supplemental Figure Legends from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Supplemental Methods from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Supplemental Figure Legends from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Supplementary Table 1 from eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival
2023Open Access
Supplementary Table 1 from eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival
2023Open Access
Data from eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival
2023Open Access
Data from eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival
2023Open Access
NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer
Genes·2023· 6 citedOpen Access
Abstract 5130: Prognostic significance of loss of Cathepsin L expression in urinary bladder cancer progression
Cancer Research·2022
Abstract 2267: Alterations in TGFβ signaling in ovarian cancer patients with TGFβ receptor 1 variants
Cancer Research·2021
An Unusual Cause of Concordance in the Setting of Left Bundle Branch Block
Journal of Family Medicine·2021Open Access
Abstract 747: Pak1, TGFα, Ki 67 and survival in human gastric and gastroesophageal junction adenocarcinomas
Cancer Research·2020
Transcription factors WT1 and p53 combined: a prognostic biomarker in ovarian cancer
British Journal of Cancer·2018· 34 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

James A. Deddens(11), Jeremy R. Graff(10), Larry E. Douglass(10), Bruce M. Colligan(10), Anthony B. DeAngelo(8), Harry W. Carter(6), Jackson O. Pemberton(6), Bruce W. Konicek(5), Bernadette M. Hurst(5), Raymond E. Richmond(5), H W Carter(4), Blake Lee Neubauer(3), Taiping Chen(3), J. Bird(3), Welch Cs(3), Florian Daniel(3), Michael H. George(3), R. D. Poretz(3), Rebecca L. Lynch(2), Michele Dowless(2)